Halaman 3 - Mieloma Dokter Terbaik - TOP-73 dokter

Prof. Dr. Atilla Ozkan adalah ahli hematologi terkemuka yang berspesialisasi dalam pengobatan mieloma, dengan pengalaman luas dalam transplantasi sel punca dan aferesis.

• Pengalaman lebih dari 20 tahun di bidang hematologi dan penyakit dalam
• Presiden Asosiasi Aferesis Terapeutik Turki saat ini
• Berspesialisasi dalam transplantasi sel punca autologus dan alogenik
• Tersertifikasi oleh EBMT untuk kursus transplantasi sel punca
• Profesor di Fakultas Kedokteran Universitas Yeditepe

Dr. Weidmann mengepalai sektor Hematologi di Klinik Nordwest dengan pengalaman lebih dari 34 tahun spesialisasi dalam kelainan darah, termasuk mieloma.

• Lebih dari 1.100 prosedur dilakukan
• Spesialisasi dalam pengobatan limfoma Non-Hodgkin
• Profesor dengan latar belakang akademik yang luas

Dr. Alemdar ahli dalam pengobatan mieloma dengan pelatihan ekstensif dalam onkologi medis di Universitas Akdeniz.

• Tersertifikasi dewan dalam onkologi medis sejak 2018
• Pengalaman lebih dari 15 tahun di bidang penyakit dalam dan onkologi
• Pernah bekerja di Rumah Sakit Universitas Akdeniz, sebuah institusi medis terkemuka
• Anggota Asosiasi Onkologi Medis Turki

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Onkohematolog Ofer Spielberg menangani kanker darah di Assuta Medical Center.

• Spesialisasi khusus dalam menangani mieloma dan gangguan darah lainnya
• Bekerja di dalam jaringan rumah sakit besar Israel yang dikenal dengan onkologi mutakhir

Profesor Ben-Yehuda adalah Kepala Hematologi di Hadassah Medical Center dan Dekan Fakultas Kedokteran yang diakui.

• Memiliki pengalaman lebih dari 30 tahun dalam menangani penyakit darah ganas termasuk mieloma
• Menempuh pelatihan di Memorial Sloan-Kettering Cancer Center yang bergengsi di New York
• Spesialisasi dalam transplantasi sumsum tulang dan terapi gen lanjutan
• Memimpin penelitian dalam diagnostik molekuler untuk penyakit hematologi
• Penerima penghargaan Healing with the Heart untuk perawatan pasien yang luar biasa

Prof. Bosch memimpin 80+ uji klinis untuk mieloma dan leukemia, merintis perawatan baru di Quironsalud Barcelona. Penelitiannya membentuk terapi masa depan di seluruh dunia.

• Kepala Hematologi di IOB Institute of Oncology sejak 2004
• Menerbitkan 100+ studi di jurnal seperti The New England Journal of Medicine
• Presiden kelompok riset leukemia limfositik kronis Spanyol (GELLC)
• Menjalani pelatihan di Columbia University's Institute of Cancer Genetics

Prof. Serdar Bedii Omay telah menerbitkan 65+ artikel ilmiah tentang hematologi dan transplantasi sumsum tulang, dengan pengalaman penelitian yang luas.

• Menjalani pelatihan di Fakultas Kedokteran Mie Jepang dalam hematologi molekuler
• Menjadi profesor hematologi di berbagai universitas di Turki
• Mengambil spesialisasi dalam hematologi klinis dan penelitian tingkat lanjut
• Menjadi mantan asisten profesor di departemen hematologi Universitas Ege

Associate Professor di bidang Hematologi dengan 50+ publikasi—Dr. Eren berspesialisasi dalam Myeloma di Rumah Sakit Universitas Biruni.

• Menyelesaikan pelatihan lanjutan di Rumah Sakit Pendidikan dan Penelitian Istanbul
• Menjadi anggota European Society of Hematology dan Turkish Hematology Association
• Menjadi penerima berbagai penghargaan untuk penelitian hematologi
• Fasih berbahasa Inggris untuk konsultasi pasien internasional

Dr. Apak memiliki pengalaman lebih dari 24 tahun memimpin Divisi Hematologi-Onkologi Anak di Universitas Istanbul-Cerrahpaşa – salah satu institusi medis terkemuka di Turki.

• Spesialisasi dalam transplantasi sumsum tulang dan terapi sel CAR-T untuk kasus pediatrik
• Menerbitkan 75 makalah internasional tentang perawatan onkologi pediatrik
• Mantan editor Turkish Pediatrics Archives – memastikan perawatan berbasis bukti
• Kepala hematologi-onkologi pediatrik saat ini di Rumah Sakit Universitas Biruni

Prof. Baytan berspesialisasi dalam kanker anak-anak dengan 15+ artikel internasional yang telah diterbitkan. Ia memimpin departemen hematologi pediatrik di Rumah Sakit Emsey.

• Menjadi ahli dalam leukemia, limfoma, dan penyakit pendarahan pada anak
• Menerbitkan 15 artikel di jurnal wasit internasional
• Menulis 3 buku tentang hematologi pediatrik
• Berspesialisasi dalam pengobatan anemia dan defisiensi vitamin